Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Markowitz

Showing results (61-70 of 604) with videos related to

Pageof 61
Sort By:
Psychopharmacology Bulletin|October 26, 2002
The emerging recognition of herb-drug interactions with a focus on St. John's wort (Hypericum perforatum)J S Markowitz, C L DeVane
Journal of Clinical Psychopharmacology|February 1, 2000
Rifampin-induced selective serotonin reuptake inhibitor withdrawal syndrome in a patient treated with sertralineJ S Markowitz, C L DeVane
Bulletin of the Menninger Clinic|March 1, 2000
Avoiding psychotropic drug interactions in the cardiovascular patientC L DeVane, J S Markowitz
Journal of Clinical Psychopharmacology|June 1, 1999
Suspected ciprofloxacin inhibition of olanzapine resulting in increased plasma concentrationJ S Markowitz, C L DeVane
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|March 1, 1996
"Smart drugs"?W H Carson, J S Markowitz
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|June 1, 1996
Savings on nutritional supplements administered to patients with chronic alcoholismJ S Markowitz, C W Jackson
Current Opinion in Nephrology and Hypertension|April 18, 2009
Classification of lupus nephritisGlen S Markowitz, Vivette D D'Agati
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 22, 2008
Activation of the antiviral prodrug oseltamivir is impaired by two newly identified carboxylesterase 1 variantsHao-Jie Zhu, John S Markowitz
Expert Opinion on Drug Metabolism & Toxicology|July 15, 2014
A pharmacokinetic evaluation of oral edivoxetine hydrochloride for the treatment of attention deficit-hyperactivity disorderJohn S Markowitz, Bryan J Brinda
Journal of Clinical Psychopharmacology|June 18, 2008
Given the multifaceted nature of ADHD, namely its physiologic, cognitive, psychological, and behavioral manifestations, multimodal approaches to treatment are advocated. IntroductionJohn S Markowitz, Kennerly S Patrick
Pageof 61

Showing results (61-70 of 604) with videos related to

Sort By:
Pageof 61
Psychopharmacology Bulletin|October 26, 2002
The emerging recognition of herb-drug interactions with a focus on St. John's wort (Hypericum perforatum)J S Markowitz, C L DeVane
Journal of Clinical Psychopharmacology|February 1, 2000
Rifampin-induced selective serotonin reuptake inhibitor withdrawal syndrome in a patient treated with sertralineJ S Markowitz, C L DeVane
Bulletin of the Menninger Clinic|March 1, 2000
Avoiding psychotropic drug interactions in the cardiovascular patientC L DeVane, J S Markowitz
Journal of Clinical Psychopharmacology|June 1, 1999
Suspected ciprofloxacin inhibition of olanzapine resulting in increased plasma concentrationJ S Markowitz, C L DeVane
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|March 1, 1996
"Smart drugs"?W H Carson, J S Markowitz
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|June 1, 1996
Savings on nutritional supplements administered to patients with chronic alcoholismJ S Markowitz, C W Jackson
Current Opinion in Nephrology and Hypertension|April 18, 2009
Classification of lupus nephritisGlen S Markowitz, Vivette D D'Agati
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 22, 2008
Activation of the antiviral prodrug oseltamivir is impaired by two newly identified carboxylesterase 1 variantsHao-Jie Zhu, John S Markowitz
Expert Opinion on Drug Metabolism & Toxicology|July 15, 2014
A pharmacokinetic evaluation of oral edivoxetine hydrochloride for the treatment of attention deficit-hyperactivity disorderJohn S Markowitz, Bryan J Brinda
Journal of Clinical Psychopharmacology|June 18, 2008
Given the multifaceted nature of ADHD, namely its physiologic, cognitive, psychological, and behavioral manifestations, multimodal approaches to treatment are advocated. IntroductionJohn S Markowitz, Kennerly S Patrick
Pageof 61